Secondary Outcomes of a Pilot Randomized Trial of Azithromycin Treatment for Asthma
2006

Azithromycin Treatment for Asthma

Sample size: 45 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hahn David L, Plane Mary Beth, Mahdi Olaimatu S, Byrne Gerald I

Primary Institution: Dean Medical Center, East Clinic, Madison, Wisconsin, United States of America

Hypothesis

Does azithromycin treatment affect asthma outcomes in adults with stable, persistent asthma?

Conclusion

Azithromycin did not improve quality of life but appeared to improve overall asthma symptoms.

Supporting Evidence

  • Participants receiving azithromycin showed a 28% improvement in overall asthma symptoms compared to 12% in those with low IgA levels.
  • Juniper AQLQ scores improved by 0.25 units in the azithromycin group.
  • Overall asthma symptoms improved by 0.68 units in the azithromycin group.

Takeaway

This study looked at whether an antibiotic called azithromycin could help people with asthma feel better. It found that while it didn't make their quality of life better, it did help with their overall asthma symptoms.

Methodology

A randomized, placebo-controlled, blinded trial with 45 adults receiving either azithromycin or placebo over 3 months.

Potential Biases

Randomization failed to achieve gender balance.

Limitations

The study was small and had a short duration, and the outcome measures varied in validation.

Participant Demographics

Adults with stable, persistent asthma, mostly mild to moderate severity.

Statistical Information

P-Value

0.04

Confidence Interval

−0.3, 0.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pctr.0010011

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication